Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead.

BACKGROUND As a result of longer follow-up after implantation of cardioverter defibrillators (ICD), fatigue of the leads has become a concern. The aim of this study was to determine the incidence and clinical presentation of ICD lead failures. METHODS AND RESULTS The study population consisted of 241 patients with 249 ICD leads who underwent implantation of an ICD with a transvenous lead system. After device implantation, the patients were routinely followed up every 4 months. Five lead failures (2.0%) occurred as an oversensing of artifact during the follow-up period (2.6+/-2.1 years); 4 of those 5 patients received inappropriate shocks and 1 case of lead failure was identified in a patient with frequent episodes of non-sustained ventricular fibrillation. In particular, the right ventricular polyurethane transvenous lead in the Medtronic model 6936 failed in 4 (13%) of 31 cases. Percutaneous lead extraction was not available in all cases, so an additional ICD lead was inserted through the same site of the subclavian vein. CONCLUSIONS Lead failures may occur 5 years after ICD implantation and polyurethane leads have an especially high incidence of failure. However, there were no follow-up parameters observed that predicted lead failures.

[1]  D. Hayes,et al.  A Multicenter Experience with a Bipolar Tined Polyurethane Ventricular Lead , 1992, Pacing and clinical electrophysiology : PACE.

[2]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[3]  S. Furman,et al.  Insulation Lead Failure: Is it a Matter of Insulation Coating, Venous Approach, or Both? , 1998, Pacing and clinical electrophysiology : PACE.

[4]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[5]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[6]  Victor Parsonnet,et al.  Long‐Term Structural Failure of Coaxial Polyurethane Implantable Cardioverter Defibrillator Leads , 2002, Pacing and clinical electrophysiology : PACE.

[7]  Tim Vaughn,et al.  Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. , 2003, Journal of the American College of Cardiology.

[8]  M. Velinovic,et al.  Fracture of the subcutaneous patch electrode in a patient with an implanted cardioverter-defibrillator. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[9]  D. Cannom,et al.  High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[10]  Uwe Dorwarth,et al.  Transvenous Defibrillation Leads: High Incidence of Failure During Long‐Term Follow‐Up , 2003, Journal of cardiovascular electrophysiology.

[11]  T. Katagiri,et al.  Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? , 2005, Circulation journal : official journal of the Japanese Circulation Society.